Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02624622 · ClinicalTrials.gov registry record · NA

Chlorhexidine Cord Care for Newborn Infants in Kenya

A NA study, sponsored by University of New Mexico.

Terminated
Registry status
NA
Development phase
576
Enrollment target

NCT02624622 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 576 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02624622, a NA study, was terminated before completion, sponsored by University of New Mexico.

TERMINATED
Registry status
NA
Development phase
576 participants
Enrollment target

Study Summary

Studies in several countries with a high rate of death of infants during the first week of life have found a reduction in infection and mortality when chlorhexidine is applied to the umbilical cord stump by a health worker within 24 hours of birth. This study will evaluate if providing chlorhexidine to pregnant women during a prenatal care visit for application to the cord stump after birth will be as effective for preventing omphalitis (infection of the umbilical cord stump) as sending a community health worker into the home to apply the chlorhexidine.

Interventions

  • PROCEDURE Chlorhexidine application to cord by mother
  • PROCEDURE Chlorhexidine application by CHW

Trial Details

FieldValue
Enrollment Target 576 participants
Start Date 2015-03
Est. Completion 2017-01
Phase NA

Sponsor

University of New Mexico

168 total trials

What the Registry Record Tells You About NCT02624622

The ClinicalTrials.gov registry entry for NCT02624622 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 576 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine application to cord by mother is the first listed.

NCT02624622 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02624622 about?

NCT02624622 is a clinical study titled "Chlorhexidine Cord Care for Newborn Infants in Kenya". Studies in several countries with a high rate of death of infants during the first week of life have found a reduction in infection and mortality when chlorhexidine is applied to the umbilical cord stump by a health worker within 24 hours of birth. This study will evaluate if providing chlorhexidine...

What is the current status of trial NCT02624622?

This trial is currently terminated. It is a NA study. The enrollment target is 576 participants. The study started on 2015-03. Estimated completion is 2017-01.

What interventions are being tested in trial NCT02624622?

The interventions under investigation include: Chlorhexidine application to cord by mother (PROCEDURE), Chlorhexidine application by CHW (PROCEDURE).

Who is sponsoring clinical trial NCT02624622?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.